HGH Fragment 176-191 CJC-1295 No DAC Spray

Product Overview

HGH Fragment 176-191 CJC-1295 No DAC Spray is a sophisticated dual-peptide research formulation available exclusively at Direct Anti Peptide. This product combines two well-characterized peptide compounds — HGH Fragment 176-191 and CJC-1295 No DAC — into a single nasal spray matrix, designed to support advanced investigations into growth hormone modulation, metabolic signaling, and related biochemical pathways. Researchers seeking a high-purity, analytically verified peptide blend for sale will find this product ideally positioned for rigorous in vitro and preclinical study protocols.

Peptide Structure & Amino Acid Sequence

HGH Fragment 176-191 is a truncated analogue of the human growth hormone polypeptide, corresponding specifically to amino acid residues 176 through 191 of the native GH sequence. This C-terminal fragment retains structural elements associated with lipolytic signaling while omitting the anabolic domains of full-length GH. CJC-1295 No DAC is a synthetic growth hormone-releasing hormone (GHRH) analogue engineered without the Drug Affinity Complex (DAC) modification, resulting in a shorter half-life profile compared to its DAC-containing counterpart. Together, these two peptides represent complementary targets within the GH axis, making this blend a compelling subject for combinatorial peptide research.

Chemical & Physical Characteristics

• Formulation: Dual-peptide nasal spray blend
• Total Peptide Content: 2.5 mg per 15 ml (CJC-1295 No DAC: 0.8 mg | HGH Fragment 176-191: 1.7 mg)
• Volume: 15 ml spray solution
• Purity: ≥98% (each peptide component)
• Appearance: Clear to slightly opalescent aqueous solution
• Delivery Format: Nasal spray with metered-dose applicator
• Molecular Basis: Synthetic peptide analogues produced via solid-phase peptide synthesis (SPPS)

Purity & Analytical Verification (HPLC & MS)

Every batch of HGH Fragment 176-191 CJC-1295 No DAC Spray supplied by Direct Anti Peptide undergoes stringent analytical verification. High-Performance Liquid Chromatography (HPLC) is employed to confirm peptide purity at ≥98% for each active component, while Mass Spectrometry (MS) validates correct molecular weight and sequence integrity. These dual analytical methods ensure that researchers receive a product of consistent, documented quality suitable for reproducible experimental outcomes. Certificates of Analysis (CoA) reflecting these results are available upon request.

Quality Control & Lyophilization Integrity

While this formulation is presented as a ready-to-use spray solution rather than a lyophilized powder, Direct Anti Peptide applies equivalent quality control standards across all product formats. Formulation integrity is maintained through controlled manufacturing conditions, sterile filtration protocols, and appropriate excipient selection to preserve peptide stability in solution. Each unit is inspected prior to dispatch to confirm fill volume, clarity, and absence of particulate matter, ensuring that the research-grade standard is upheld throughout the supply chain.

Safety, Handling & Laboratory Precautions

This product is intended exclusively for use by qualified research professionals in properly equipped laboratory settings. Standard laboratory personal protective equipment (PPE) — including gloves, safety eyewear, and lab coats — should be worn when handling peptide solutions. Avoid contact with skin, eyes, and mucous membranes during handling. Do not ingest or administer to humans or animals under any circumstances. Dispose of unused material in accordance with applicable institutional and local regulatory waste disposal guidelines.

Reconstitution, Packaging & Storage

This product is supplied as a pre-formulated nasal spray solution and does not require reconstitution prior to research use. The 15 ml spray bottle should be stored at 2–8°C (refrigerated) when not in active use, protected from direct light and heat sources. Avoid freezing the spray solution, as this may compromise peptide stability and spray mechanism integrity. Once opened, use within the timeframe specified on the product label or CoA documentation. Always keep out of reach of unauthorized personnel.

Intended Research Use & Market Positioning

The HGH Fragment 176-191 CJC-1295 No DAC Spray is positioned as a premium research tool for scientists and institutions investigating GH axis signaling, metabolic regulation, lipolytic mechanisms, and GHRH receptor pharmacology. The combinatorial nature of this blend provides a unique platform for studying the synergistic interactions between a GH fragment and a GHRH analogue within a single, controlled delivery format. Direct Anti Peptide offers this product at a competitive best price, making it accessible to research teams requiring reliable, high-purity peptide blends for ongoing studies.

Ordering, Availability & Fulfillment

Researchers can conveniently buy HGH Fragment 176-191 CJC-1295 No DAC Spray online directly through the Direct Anti Peptide store. Orders are processed promptly, with secure packaging designed to maintain cold-chain integrity during transit. We offer transparent pricing, fast dispatch, and responsive customer support for research institutions and individual scientists alike. Order now to benefit from our streamlined fulfillment process and ensure your laboratory maintains an uninterrupted supply of analytically verified research peptides.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. HGH Fragment 176-191 CJC-1295 No DAC Spray is sold exclusively as a laboratory research reagent by Direct Anti Peptide. This product has not been evaluated or approved by any regulatory authority for therapeutic, prophylactic, or diagnostic use in humans or animals. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international laws and regulations governing the acquisition, possession, and use of research peptides. Direct Anti Peptide makes no claims regarding the safety, efficacy, or suitability of this product for any application beyond controlled scientific research.